Skip to main content

From the helm: Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley

Grady Wulff
November 8, 2022
In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley.
Starpharma Holdings Limited (ASX:SPL) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers. In this video Dr. Fairley discusses:
  • (0:56) A brief overview of Starpharma
  • (2:31) Growing distribution network for Viraleze
  • (3:29) SPL’s exciting oncology portfolio and key partnerships with major companies
  • (4:56) How Viraleze works and the market opportunity going forward
  • (6:09) What’s coming up next for SPL

Note: This interview was filmed on 20 October 2022.

Morning Bell 24 November

Sam Kanaan
November 24, 2023

Morning Bell 23 November

Grady Wulff
November 23, 2023

Morning Bell 22 November

Grady Wulff
November 22, 2023

Morning Bell 21 November

Sam Kannan
November 21, 2023

Morning Bell 20 November

Grady Wulff
November 20, 2023

Weekly Wrap 17 November

Grady Wulff
November 17, 2023

Morning Bell 17 November

Sam Kanaan
November 17, 2023

Morning Bell 16 November

Sam Kanaan
November 16, 2023

Morning Bell 15 November

Grady Wulff
November 15, 2023

Morning Bell 14 November

Sam Kanaan
November 14, 2023

Morning Bell 13 November

Sophia Mavridis
November 13, 2023